Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic.

Arrhythmias, Cardiac / complications Betacoronavirus COVID-19 Coronavirus Infections / complications Health Personnel Heart Diseases / complications Humans Myocarditis / complications Pandemics Pneumonia, Viral / complications Risk Factors SARS-CoV-2 Triage
cardiovascular therapy coronavirus health system

Journal

Journal of the American College of Cardiology
ISSN: 1558-3597
Titre abrégé: J Am Coll Cardiol
Pays: United States
ID NLM: 8301365

Informations de publication

Date de publication:
12 05 2020
Historique:
received: 17 03 2020
accepted: 17 03 2020
pubmed: 24 3 2020
medline: 20 5 2020
entrez: 24 3 2020
Statut: ppublish

Résumé

The coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 that has significant implications for the cardiovascular care of patients. First, those with COVID-19 and pre-existing cardiovascular disease have an increased risk of severe disease and death. Second, infection has been associated with multiple direct and indirect cardiovascular complications including acute myocardial injury, myocarditis, arrhythmias, and venous thromboembolism. Third, therapies under investigation for COVID-19 may have cardiovascular side effects. Fourth, the response to COVID-19 can compromise the rapid triage of non-COVID-19 patients with cardiovascular conditions. Finally, the provision of cardiovascular care may place health care workers in a position of vulnerability as they become hosts or vectors of virus transmission. We hereby review the peer-reviewed and pre-print reports pertaining to cardiovascular considerations related to COVID-19 and highlight gaps in knowledge that require further study pertinent to patients, health care workers, and health systems.

Identifiants

DOI: 10.1016/j.jacc.2020.03.031 PMID: 32201335 PMC: PMC7198856
pubmed: 32201335
pii: S0735-1097(20)34637-4
doi: 10.1016/j.jacc.2020.03.031
pmc: PMC7198856
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2352-2371

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Références

Circulation. 2016 Aug 9;134(6):e32-69
pubmed: 27400984
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
J Heart Lung Transplant. 2020 May;39(5):408-409
pubmed: 32253113
Am J Hematol. 2020 Jun;95(6):E131-E134
pubmed: 32129508
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
J Clin Invest. 2017 Jan 3;127(1):1-4
pubmed: 28045402
J Infect Dev Ctries. 2020 Feb 29;14(2):125-128
pubmed: 32146445
Curr Trop Med Rep. 2020;7(2):61-64
pubmed: 32219057
Prog Cardiovasc Dis. 2020 May - Jun;63(3):390-391
pubmed: 32169400
JAMA. 2020 Apr 21;323(15):1439-1440
pubmed: 32163102
Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
Int J Infect Dis. 2020 Apr;93:201-204
pubmed: 32097725
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
JAMA. 2020 Apr 21;323(15):1499-1500
pubmed: 32159735
Cell Res. 2020 Mar;30(3):269-271
pubmed: 32020029
Intern Med. 2015;54(16):2017-9
pubmed: 26278294
N Engl J Med. 2018 Jan 25;378(4):345-353
pubmed: 29365305
MMWR Morb Mortal Wkly Rep. 2009 Aug 21;58(32):893-6
pubmed: 19696719
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Biosci Trends. 2020 Mar 16;14(1):72-73
pubmed: 32074550
N Engl J Med. 2020 Apr 2;382(14):1370-1371
pubmed: 32163697
Clin Res Cardiol. 2020 May;109(5):531-538
pubmed: 32161990
Nature. 2013 Nov 28;503(7477):535-8
pubmed: 24172901
Clin Pharmacokinet. 2018 Oct;57(10):1347-1354
pubmed: 29453687
Blood Adv. 2018 Nov 27;2(22):3257-3291
pubmed: 30482765
Ann Pharmacother. 2016 Nov;50(11):909-917
pubmed: 27465881
Thorax. 2004 Mar;59(3):252-6
pubmed: 14985565
J Am Heart Assoc. 2018 Jan 26;7(3):
pubmed: 29374046
J Am Coll Cardiol. 2018 Oct 30;72(18):2231-2264
pubmed: 30153967
Intensive Care Med. 2020 Apr;46(4):586-590
pubmed: 32125455
Circulation. 2017 Nov 14;136(20):1955-1975
pubmed: 29084738
Herz. 2020 May;45(3):230-232
pubmed: 32140732
JAMA. 1994 Dec 7;272(21):1661-5
pubmed: 7966893
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
Life Sci. 2020 May 1;248:117477
pubmed: 32119961
J Am Coll Cardiol. 2009 Dec 1;54(23):2129-38
pubmed: 19942084
Eur Respir Rev. 2014 Dec;23(134):519-30
pubmed: 25445951
J Heart Lung Transplant. 2020 May;39(5):496-497
pubmed: 32362394
J Microbiol Immunol Infect. 2020 Jun;53(3):371-372
pubmed: 32147409
BMJ. 2020 Feb 18;368:m641
pubmed: 32071063
Ann Saudi Med. 2016 Jan-Feb;36(1):78-80
pubmed: 26922692
JAMA Netw Open. 2019 Dec 2;2(12):e1916526
pubmed: 31790569
N Engl J Med. 2019 Dec 12;381(24):2293-2303
pubmed: 31774950
Nat Rev Immunol. 2015 Feb;15(2):104-16
pubmed: 25614320
Am J Med. 2016 Apr;129(4):446.e5-446.e21
pubmed: 26593739
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Nature. 2005 Jul 7;436(7047):112-6
pubmed: 16001071
JAMA. 2020 Apr 7;323(13):1245-1246
pubmed: 32074258
Br J Clin Pharmacol. 2013 Sep;76(3):455-66
pubmed: 23305158
Minerva Cardioangiol. 2020 Apr;68(2):61-64
pubmed: 32150358
Chest. 2007 Apr;131(4):964-71
pubmed: 17426196
Intensive Care Med. 2012 Oct;38(10):1573-82
pubmed: 22926653
Cell Res. 2008 Feb;18(2):290-301
pubmed: 18227861
Trends Microbiol. 2016 Jun;24(6):490-502
pubmed: 27012512
N Engl J Med. 2020 Apr 30;382(18):1679-1681
pubmed: 32160451
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
J Am Coll Cardiol. 2020 May 12;75(18):2372-2375
pubmed: 32199938
Eur Heart J. 2021 Jan 7;42(2):206
pubmed: 32176300
BMJ. 2020 Mar 13;368:m1054
pubmed: 32169834
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
J Hosp Infect. 2006 Dec;64(4):371-8
pubmed: 17046110
Circulation. 2005 May 24;111(20):2605-10
pubmed: 15897343
Thromb Res. 2020 Jul;191:145-147
pubmed: 32291094
J Am Coll Cardiol. 2006 Oct 3;48(7):1498-502
pubmed: 17010820
J Med Virol. 2020 Jun;92(6):577-583
pubmed: 32162702
Sci China Life Sci. 2020 Mar;63(3):364-374
pubmed: 32048163
Immunopharmacol Immunotoxicol. 2013 Jun;35(3):434-42
pubmed: 23635029
BMJ. 2020 Mar 17;368:m1086
pubmed: 32184201
J Thromb Haemost. 2020 May;18(5):1094-1099
pubmed: 32220112
Hum Vaccin. 2011 Jan-Feb;7 Suppl:94-8
pubmed: 21301210
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
Drug Dev Res. 2020 Aug;81(5):537-540
pubmed: 32129518
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
J Hypertens. 2018 Oct;36(10):1953-2041
pubmed: 30234752
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
J Heart Lung Transplant. 2009 Dec;28(12):1341-7
pubmed: 19854073
Clin Pharmacol Ther. 2019 Jan;105(1):219-228
pubmed: 29696643
Intensive Care Med. 2020 Jun;46(6):1111-1113
pubmed: 32162032
Br J Clin Pharmacol. 2015 May;79(5):838-46
pubmed: 25377242
Nat Rev Cardiol. 2020 May;17(5):259-260
pubmed: 32139904
Chin Med J (Engl). 2020 May 5;133(9):1025-1031
pubmed: 32044814
Circ Cardiovasc Qual Outcomes. 2020 Apr;13(4):e006631
pubmed: 32182131
Euro Surveill. 2020 Mar;25(10):
pubmed: 32183930

Auteurs

Elissa Driggin (E)

New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York.

Mahesh V Madhavan (MV)

New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York.

Behnood Bikdeli (B)

New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Center for Outcomes Research and Evaluation, Yale School of Medicine, New Haven, Connecticut.

Taylor Chuich (T)

New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York.

Justin Laracy (J)

New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York.

Giuseppe Biondi-Zoccai (G)

Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy; Mediterranea Cardiocentro, Napoli, Italy.

Tyler S Brown (TS)

Massachusetts General Hospital, Boston, Massachusetts.

Caroline Der Nigoghossian (C)

New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York.

David A Zidar (DA)

Case Western Reserve School of Medicine, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio.

Jennifer Haythe (J)

New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York.

Daniel Brodie (D)

New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York.

Joshua A Beckman (JA)

Vanderbilt University Medical Center, Nashville, Tennessee.

Ajay J Kirtane (AJ)

New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York.

Gregg W Stone (GW)

Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Icahn School of Medicine at Mount Sinai, New York, New York.

Harlan M Krumholz (HM)

Center for Outcomes Research and Evaluation, Yale School of Medicine, New Haven, Connecticut; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut; Department of Health Policy and Administration, Yale School of Public Health, New Haven, Connecticut.

Sahil A Parikh (SA)

New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York. Electronic address: sap2196@cumc.columbia.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Troubles du rythme cardiaque › Cardiovascular Considerations for Patients,...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Cardiovascular Considerations for Patients,...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › Cardiovascular Considerations for Patients,...
questionsmedicales.fr › Infection › Maladies virales › Infections à virus à ARN › Infections à Nidovirales › Infections à Coronaviridae › Infections à coronavirus › Cardiovascular Considerations for Patients,...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Personnel de santé › Cardiovascular Considerations for Patients,...
questionsmedicales.fr › Maladies cardiovasculaires › Cardiopathies › Cardiovascular Considerations for Patients,...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Cardiovascular Considerations for Patients,...
questionsmedicales.fr › Maladies cardiovasculaires › Cardiopathies › Cardiomyopathies › Myocardite › Cardiovascular Considerations for Patients,...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Épidémies de maladies › Épidémies › Pandémies › Cardiovascular Considerations for Patients,...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › Cardiovascular Considerations for Patients,...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Cardiovascular Considerations for Patients,...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › Cardiovascular Considerations for Patients,...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Services de santé › Services des urgences médicales › Triage › Cardiovascular Considerations for Patients,...